Study site | Year | Village | Time relative to MDA (week) | |||||
---|---|---|---|---|---|---|---|---|
Week -3 | Week -2 | Week -1 | Week 1 | Week 2 | Week 3 | |||
Burkina Faso | 2013 (Aug.-Sept.) | Control | 0.96 ± 0.02 (89) | 0.70 ± 0.05 (70) | NA | 0.71 ± 0.03 (266) | 0.651 ± 0.04 (129) | 0.89 ± 0.05 (45) |
Treated | 0.85 ± 0.04 (75) | 0.75 ± 0.04 (122) | NA | 0.50 ± 0.03 (329) | 0.709 ± 0.03 (196) | 0.81 ± 0.06 (41) | ||
p-value | 0.0477 | 0.6029 | - | 1.54E-07 | 0.3268 | 0.4325 | ||
Liberia | 2013 (June) | Control | NA | NA | NA | NA | NA | NA |
Treated | NA | 0.98 ± 0.01 (104) | 0.91 ± 0.04 (66) | 0.42 ± 0.04 (147) | 0.86 ± 0.05 (50) | NA | ||
p-value | - | - | - | - | - | - | ||
Senegal | 2009 (Oct.) | Control | NA | NA | 0.83 ± 0.06 (40) | 0.81 ± 0.05 (62) | 0.792 ± 0.08 (24) | NA |
Treated | NA | NA | 0.79 ± 0.02 (338) | 0.48 ± 0.04 (168) | 0.75 ± 0.06 (48) | NA | ||
p-value | - | - | 0.7879 | 1.5E-05 | 0.9218 | - | ||
2009 (July-Aug.) | Control | NA | 0.77 ± 0.08 (26) | 0.61 ± 0.09 (33) | 0.72 ± 0.06 (60) | 0.833 ± 0.07 (30) | NA | |
Treated | NA | 0.90 ± 0.04 (59) | 0.82 ± 0.03 (154) | 0.57 ± 0.04 (150) | 0.819 ± 0.03 (160) | NA | ||
p-value | - | 0.2162 | 0.015 | 0.077 | 1 | - | ||
2008 (Aug.) | Control | NA | NA | 0.76 ± 0.07 (37) | 1.0 ± 0 (26) | 0.842 ± 0.08 (19) | NA | |
Treated | NA | NA | 0.70 ± 0.05 (89) | 0.40 ± 0.06 (70) | 0.636 ± 0.15 (11) | NA | ||
p-value | - | - | 0.6427 | 4.78E-07 | 0.4031 | - |